StemCyte Receives Phase II Investigational New Drug (IND) Clearance from the U.S. Food and Drug Administration (FDA) Jan 3, 2019 Life Science
China SXT Pharmaceuticals, Inc. Announces First Closing of Initial Public Offering Jan 3, 2019 Life Science
Promega Microsatellite Instability Technology Receives Innovation Designation from Chinese National Medical Products Administration Jan 2, 2019 Life Science
Luye Pharma Announces Innovative Drug – Risperidone Extended Release Microspheres for Injection has Reached Final Stage of NDA Process Dec 31, 2018 Life Science
Betta Acquires China Rights to InventisBio EGFR-Inhibitor for $33.5 Million Dec 31, 2018 Life Science
Amazon gets into health insurance — and more 2019 health-tech predictions from top experts Dec 28, 2018 Life Science, Technology
Green Growth Brands to launch bid for marijuana producer Aphria Dec 28, 2018 Life Science, Technology
FibroGen/AstraZeneca Novel Anemia Drug Approved in China — Before US/EU Approvals Dec 28, 2018 Life Science
